4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-025110
Chief Executive Officer sold 5,000 shares at $8.10 ($40,496)
- Chief Executive Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Townsend Richard Nolan Chief Executive Officer | 2024-10-10 | Option exercise 10b5-1 | +5,000 | $2.33 | $11,650 | 125,695 | D |
| Townsend Richard Nolan Chief Executive Officer | 2024-10-10 | Sale 10b5-1 | −5,000 | $8.10 | $40,496 | 120,695 | D |
| Derivatives | |||||||
| Townsend Richard Nolan Chief Executive Officer | 2024-10-10 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 123,655 | D | ||
| Open-market sales · 5,000 sh · avg $8.10 · $40,496 | |||||||
Loading xslF345X05/form4-10152024_011001.xml…